Abstracts tagged "endothelial cells and systemic sclerosis"

Abstract Number: 772 • 2017 ACR/ARHP Annual Meeting
Molecular Mechanism for the Therapeutic Effect of Extracorporeal Shock Wave Therapy on Digital Ulcers of Systemic Sclerosis
Yukiko Kamogawa¹, Hiroshi Fujii¹, Tsuyoshi Shirai¹, Tomonori Ishii² and Hideo Harigae¹, ¹Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan, ²Clinical Research, Innovation and Education Center, Tohoku University Hospital, Sendai, Japan
Background/Purpose: Digital ulcers (DUs) are the most common skin manifestations in systemic sclerosis (SSc). DUs in SSc are not usually caused by vasculitis and are…
Abstract Number: 821 • 2015 ACR/ARHP Annual Meeting
Elevated Serum Levels of Soluble CD146 in Patients with Systemic Sclerosis
Kazunori Kato¹, Tomoko Ito², Naoto Tamura², Sayuri Okuda¹, Masakazu Matsushita², Kurisu Tada², Ken Yamaji² and Yoshinari Takasaki², ¹Department of Biomedical Engineering, Toyo University, Saitama, Japan, ²Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan
Background/Purpose: CD146 is a transmembrane glycoprotein belonging to Ig-superfamily. Human endothelial cells, activated fibroblasts and Th17 cells express CD146 that involved in angiogenesis, fibrosis and…
Abstract Number: 1494 • 2012 ACR/ARHP Annual Meeting
CD40 Signaling Results in Microvascular Endothelial Dysfunction: A Possible Clue to the Pathogenesis of Scleroderma Vasculopathy
Bashar Kahaleh¹ and Yongqing Wang², ¹Medicine/Rheumatology, University of Toledo, Toledo, OH, ²Medicine, University of Toledo, Toledo, OH
Background/Purpose: Increased expression of CD40 in SSc- Microvascular Endothelial Cells (MVEC) was noted on a gene expression array and increased concentrations of soluble CD40 ligand (sCD40L)…
Abstract Number: 699 • 2012 ACR/ARHP Annual Meeting
Endothelial Dysfunction and Vascular Stiffness in Early Diffuse Systemic Sclerosis
Robyn T. Domsic¹, Dana Ivanco², Hunter C. Champion³, Ali Shoushtari³ and Thomas A. Medsger Jr.⁴, ¹Medicine - Rheumatology, University of Pittsburgh, Pittsburgh, PA, ²Department of Medicine/Div. of Rheumatology, University of Pittsburgh, Pittsburgh, PA, ³Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, ⁴Medicine/Rheumatology, Univ of Pittsburgh, Pittsburgh, PA
Background/Purpose: Vascular dysfunction is a hallmark of systemic sclerosis (SSc). Current theories postulate endothelial injury and dysfunction as an early event in SSc pathogenesis. Prior…
Abstract Number: 700 • 2012 ACR/ARHP Annual Meeting
Clinical Correlation of Flow-Mediated Endothelium-Dependent Vasodilatation in Systemic Sclerosis
Takehiro Takahashi¹, Yoshihide Asano¹, Eisuke Amiya², Masaru Hatano³, Atsuko Ozeki², Aya Watanabe², Shuichi Kawarasaki², Tomoko Nakao², Zenshiro Tamaki⁴, Takashi Taniguchi⁵, Yohei Ichimura⁵, Tetsuo Toyama¹, Masafumi Watanabe⁶, Yasunobu Hirata², Ryozo Nagai³ and Shinichi Sato⁷, ¹Department of Dermatology, University of Tokyo Graduate School of Medicine, Tokyo, Japan, ²Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan, ³Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan, ⁴Medicine, Rheumatology, Department of Dermatology, University of Tokyo Graduate School of Medicine, Tokyo, Japan, ⁵Dermatology, University of Tokyo Graduate School of Medicine, Tokyo, Japan, ⁶Cardiovascular Medicine, Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan, ⁷Department of Dermatology, Faculty of Medicine, University of Tokyo, Tokyo, Japan
Background/Purpose: Systemic sclerosis (SSc) is a multisystem autoimmune disease characterized by initial vascular injuries and resultant fibrosis of skin and certain internal organs. Evidence has…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].